Previous close | 3.3000 |
Open | 3.3000 |
Bid | 2.2500 |
Ask | 4.2000 |
Strike | 10.00 |
Expiry date | 2024-06-21 |
Day's range | 3.3000 - 3.3000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
On June 10, 2024, Julie Mchugh, Director at Ironwood Pharmaceuticals Inc (NASDAQ:IRWD), executed a sale of 22,766 shares of the company.
On June 7, 2024, Catherine Moukheibir, a Director at Ironwood Pharmaceuticals Inc (NASDAQ:IRWD), executed a sale of 80,000 shares of the company.
BOSTON, May 30, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City.